WHO SHOULD TAKE BPC: Liposomal BPC is ideal for individuals with acute reparative needs: Thoserecovering from injury, surgery, or physical overexertion, those looking to support tissue healing and repair, vascular health, and neurological resilience
Is a COA available
The drug is up for approval in 2026
Huberman highlights that boosting NAD+ levels through supplementation with NMN (nicotinamide mononucleotide), a precursor to NAD+, has shown promise in animal studies for restoring mitochondrial function and promoting cellular longevity
T2D is a multifactorial, complex disease and can be controlled by diet modifications, control of physical activity, weight reduction, etc
The 30 mL plastic vial carries 9 mg/mL